Practice setting and secondary prevention of coronary artery disease

Piotr Jankowski1, Danuta Czarnecka1, Leszek Badacz2

  • 1First Department of Cardiology, Interventional Electrocardiology and Hypertension, Institute of Cardiology, Jagiellonian University Medical College, Krakow, Poland.

Insights

Cardiovascular risk control in coronary artery disease (CAD) patients saw slight improvements from 1997-2013. Primary care physicians offer the most potential for enhancing no-smoking policies and guideline-recommended drug prescriptions for better patient outcomes.

Area of Science:

  • Cardiology
  • Public Health
  • Preventive Medicine

Background:

  • Established coronary artery disease (CAD) patients face a high risk of recurrent cardiovascular events.
  • Effective implementation of cardiovascular prevention guidelines is crucial for managing this high-risk population.

Purpose of the Study:

  • To compare temporal trends in the implementation of cardiovascular prevention guidelines.
  • To assess guideline adherence by primary care physicians versus specialists in CAD patients.

Main Methods:

  • Study conducted in five Polish hospitals with cardiology departments.
  • Consecutive patients hospitalized for acute coronary syndrome or myocardial revascularization were interviewed 6-18 months post-discharge.
  • Data collected across four survey periods: 1997-1998, 1999-2000, 2006-2007, and 2011-2013.

Main Results:

  • Increased proportion of smokers observed in patients treated by primary care physicians and private cardiology practices.
  • Significant improvements noted in achieving target blood pressure and LDL cholesterol levels across all care settings.
  • Proportion of patients prescribed cardioprotective medications increased across all analyzed groups.

Conclusions:

  • Overall control of cardiovascular risk in CAD patients has shown only marginal improvement since 1997/98.
  • Primary care physicians present the greatest opportunity for further risk reduction through smoking cessation promotion and guideline-based prescribing.
  • Enhanced adherence to no-smoking policies and guideline-recommended drug prescriptions is vital for improving cardiovascular outcomes.
Abstract

Related Concept Videos

Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
699
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.1K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
480
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
276
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
385
Peripheral Artery Disease I: Introduction01:30

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...
386